p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 6, 2001, Pages 603-609

  Shin, Dong M ^a   Charuruks, Navapun ^a   Lippman, Scott M ^a   Lee, J Jack ^a   Ro, Jae Y ^a   Hong, Waun K ^a   Hittelman, Walter N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 17; CHROMOSOME 9; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC STABILITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANEUPLOIDY; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 9; DISEASE PROGRESSION; EPITHELIUM; HEAD AND NECK NEOPLASMS; HUMANS; PRECANCEROUS CONDITIONS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034904738     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Hereditary cancer, oncogenes, and antioncogenes
2. Etiology of squamous cell carcinoma
3. The multistep nature of cancer development
4. p53 and Ki67 expression in preneoplastic and neoplastic lesions of the oral mucosa
5. Cancer of the oral cavity and oropharynx
6. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers
7. Sister chromatid exchanges in the lymphocytes of patients with oral leukoplakia
8. Cytogenetic changes in rat tracheal epithelial cells during early stages of carcinogenic-induced neoplastic progression
9. The incidence of p53 mutations increases with progression of head and neck cancer
10. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: A possible molecular basis for the development of multiple tumors
11. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis
12. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis
13. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancer
14. Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells
15. Chromosome instability and its relationship to other end points of genomic instability
16. Chromosomes polysomy and histologic characteristics in oral premalignant lesions
17. Mutations in the p53 gene occur in diverse human tumor types
18. p53 mutations in human cancer
19. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinomas of the head and neck
20. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor suppressor genes
21. Analysis of genomic instability in Li-Fraumeni fibroblast with germline p53 mutations
22. Cellular injury and adaptation
23. Wild-type p53 can inhibit oncogene-mediated focus formation
24. Monoclonal antibodies to human intermediate filament protein II. Distribution of filament protein in normal tissues
25. T-antigen is bound to a host protein in SV-40 transformed cells
26. The p53 proto-oncogene can act as a suppressor of transformation
27. Genetic alterations during colorectal-tumor development
28. Widely dispersed p53 mutation in respiratory epithelium: A novel mechanism for field carcinogenesis
29. Genomic instability and the role of p53 mutations in cancer cells
30. p53 mutations, methylation, and genomic instability in the progression of chronic myeloid leukemia
31. p53 abnormalities and genomic instability in primary breast carcinomas
32. Ovarian cancer genomic instability correlates with p53 frameshift mutations
33. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma
34. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability
35. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
36. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53
37. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
38. Detection of chromosome instability of tissue fields at risk: In situ hybridization
39. Sunlight and the onset of skin cancer
40. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53
41. Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality
42. p53 and its 14 kDa c-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
43. 1 arrest, p53, and Rb
44. 1 arrest induced by ultraviolet irradiation
45. Mutations of mitotic checkpoint genes in human cancers
46. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: In vivo evidence for an association with subsequent gene amplification
47. Recent advances in chemoprevention of cancer
48. p53 and retinoid chemoprevention of oral carcinogenesis
49. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression
50. Detection of chromosome polysomy in oral leukoplakia, a premalignant lesion
51. Chromosomal instability, p53 expression, and retinoid response in oral premalignancy
52. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract